Intrinsic Novobiocin Resistance in Staphylococcus saprophyticus

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

Intrinsic novobiocin resistance in Staphylococcus saprophyticus was associated with expression of a novobiocin-resistant form of the drug target protein (GyrB). Site-directed mutagenesis established that resistance depends upon the presence of two specific amino acid residues in GyrB: a glycine at position 85 and a lysine at position 140.

Knowledge Graph

Similar Paper

Intrinsic Novobiocin Resistance in Staphylococcus saprophyticus
Antimicrobial Agents and Chemotherapy 2007.0
Site-Directed Mutagenesis Reveals Amino Acid Residues in the Escherichia coli RND Efflux Pump AcrB That Confer Macrolide Resistance
Antimicrobial Agents and Chemotherapy 2009.0
Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens.
The EMBO Journal 1988.0
Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin
Antimicrobial Agents and Chemotherapy 2009.0
A mec A -Negative Strain of Methicillin-Resistant S taphylococcus aureus with High-Level β-Lactam Resistance Contains Mutations in Three Genes
Antimicrobial Agents and Chemotherapy 2010.0
Alteration of GyrA Amino Acid Required for Ciprofloxacin Resistance in Klebsiella pneumoniae Isolates in China
Antimicrobial Agents and Chemotherapy 2008.0
Novel Apramycin Resistance Gene apmA in Bovine and Porcine Methicillin-Resistant Staphylococcus aureus ST398 Isolates
Antimicrobial Agents and Chemotherapy 2011.0
Dual Targeting of GyrB and ParE by a Novel Aminobenzimidazole Class of Antibacterial Compounds
Antimicrobial Agents and Chemotherapy 2007.0
gyrA and parC Mutations and Associated Quinolone Resistance in Vibrio anguillarum Serotype O2b Strains Isolated from Farmed Atlantic Cod ( Gadus morhua ) in Norway
Antimicrobial Agents and Chemotherapy 2007.0
Linezolid Resistance in Staphylococcus aureus : Gene Dosage Effect, Stability, Fitness Costs, and Cross-Resistances
Antimicrobial Agents and Chemotherapy 2008.0